A phase 2 trial of serplulimab in colorectal cancer, run by Zhejiang University, not yet recruiting.
16-Hour Fasting Plus Serplulimab and CAPEOX as Neoadjuvant Therapy in pMMR/MSS Advanced Mid-to-Low Rectal Cancer is a phase 2, interventional study registered as NCT07779694 by Zhejiang University, with a registry enrolment figure of 51 participants, started 2026-10-01 and due to reach its primary completion in 2028-12-31. Interventions recorded: 16-Hour Fasting; Serplulimab + chemotherapy. Conditions listed: pMMR/MSS; Locally Advanced Rectal Carcinoma; Fasting, Intermittent. Primary outcome: Pathological complete response rates. Colorectal eligibility wording from the registry: "Histological or cytological documentation of adenocarcinoma of the rectum". No results are recorded here; the registry entry is the source.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.